Nasar Ahmed: Calls for schools to stock emergency asthma kit after death of teen who fell ill in detention

Nasar Ahmed, 14, died in detention
Fiona Simpson5 May 2017

Health experts have called for every school in the UK to stock emergency asthma treatments after a teenage boy collapsed and died in detention at an east London school.

He was rushed to hospital and put on oxygen but a brain scan showed the 14-year-old was unresponsive and he died on November 14.

An inquest into his death heard the youngster died from a brain injury most likely brought on by an anaphylactic allergic reaction.

Staff who fought to save him had access to an inhaler and EpiPen from Nasar's personal medical box for five minutes before paramedics arrived, but were unsure whether to use them.

Nasar Ahmed, 14, pictured here in hospital in an image released by his family, stopped breathing in an exclusion room at Bow School in Tower Hamlets

Giving evidence at Poplar Coroner's Court, Dr Chinedu Nwokoro, a consultant and clinical academic in paediatric respiratory medicine at Barts Health NHS Trust, called for a change to advice over the use of adrenaline injectors such as EpiPens.

He said: "If (a patient) has got respiratory compromise, give it; if (they) lose consciousness, give it; if there is any doubt, give it. It's not wrong."

Coroner Mary Hassell said she would be making a number of prevention of future deaths reports and suggested she would be writing to the chief medical officer to highlight the issues and her concerns.

The inquest heard first aider Cherie Hyde and PE teacher Gemma Anderson were called to help Nasar after he began struggling to breathe during the detention period.

He called for his inhaler before collapsing and turning blue and foaming at the mouth.

The staff sought advice from a 999 call handler on whether to use an EpiPen on Nasar but did not receive an answer before paramedics arrived and took over.

The inquest heard an incorrect health care plan, containing a mistakenly downgraded allergy plan for Nasar, did not contain specific advice on when to use an EpiPen.

Create a FREE account to continue reading

eros

Registration is a free and easy way to support our journalism.

Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.

Your email address

Must be at least 6 characters, include an upper and lower case character and a number

You must be at least 18 years old to create an account

* Required fields

Already have an account? SIGN IN

By clicking Create Account you confirm that your data has been entered correctly and you have read and agree to our Terms of use , Cookie policy and Privacy policy .

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in

MORE ABOUT